Scribe Therapeutics (SCTX US)

Analysis

Health Care • United States

Scribe Therapeutics Inc. is a clinical-stage biotechnology company. The Company develops CRISPR-based genetic medicines for the treatment of cardiovascular and metabolic diseases. Scribe Therapeutics operates in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00